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Extramedullary hematopoiesis (EMH) refers to thedif-
ferentiation of hematopoietic stem cells (HSCs) into
effector cells that occurs in compartments outside
of the bone marrow. Previous studies linked pattern-
recognition receptor (PRR)-expressing HSCs, EMH,
and immune responses tomicrobial stimuli. However,
whether EMH operates in broader immune contexts
remainsunknown.Here,wedemonstrate apreviously
unrecognized role for thymic stromal lymphopoietin
(TSLP) in promoting the population expansion of pro-
genitor cells in the periphery and identify that TSLP-
elicited progenitors differentiated into effector cells
including macrophages, dendritic cells, and granulo-
cytes and that these cells contributed to type 2
cytokine responses. The frequency of circulating pro-
genitor cells was also increased in allergic patients
with a gain-of-function polymorphism in TSLP, sug-
gesting the TSLP-EMH pathway might operate in hu-
man disease. These data identify that TSLP-induced
EMH contributes to the development of allergic
inflammation and indicate that EMH is a conserved
mechanism of innate immunity.
INTRODUCTION
Hematopoietic stem cells (HSCs) circulate through the
bloodstream under steady-state conditions and accumulate in1158 Immunity 39, 1158–1170, December 12, 2013 ª2013 Elsevier Inperipheral tissues in response to stress signals such as injury
or infection (Cheshier et al., 1999; Massberg et al., 2007; Wright
et al., 2001). Peripheral HSCs are capable of differentiating into
immune effector cells via a process termed extramedullary
hematopoiesis (EMH) (Massberg et al., 2007; Nagai et al.,
2006; Ratajczak et al., 2010; Saenz et al., 2010). Although the
pathways and factors that regulate the ability of HSCs to patrol
peripheral tissues and undergo EMH remain poorly defined,
EMH has been reported to contribute to immunity and inflamma-
tion (Allakhverdi and Delespesse, 2012; Massberg et al., 2007;
Nagai et al., 2006; Ratajczak et al., 2010; Saenz et al., 2010).
For example, HSCs express germ-line encoded pattern-recogni-
tion receptors (PRRs) capable of identifying pathogen-associ-
ated molecular patterns (PAMPs) from viruses and bacteria
(Massberg et al., 2007; Nagai et al., 2006). In addition, some
HSCs express the receptors to type I and type 2 interferons
(IFNs), respond to IFN-g stimulation, and contribute to the devel-
opment of chronic intestinal inflammation in an IFN-g-dependent
manner (Baldridge et al., 2010; Griseri et al., 2012; Takizawa
et al., 2012). Collectively, these reports suggest a direct link
between EMH and the mechanisms that promote proinflamma-
tory cytokine responses associated with viral or bacterial infec-
tions. However, whether EMH is a conserved innate immune
mechanism that promotes multiple modules of the immune
system remains unknown.
Although the mechanisms through which mammalian hosts
recognize viral, bacterial, and protozoan pathogens through
PRRs and initiate T helper 1 (Th1) and Th17 cell responses are
well defined, the evolutionarily conserved mechanisms through
which Th2 cell-mediated immunity and inflammation are initiated
remain less clear (Pulendran and Artis, 2012). Emerging studies
suggest that epithelial cells provide essential signals that arec.
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ciated innate immune responses and the development of Th2
cell-dependent immunity and inflammation (Saenz et al., 2008;
Wills-Karp and Finkelman, 2011; Ziegler and Artis, 2010). For
example, the predominately epithelial cell-derived cytokines
interleukin-25 (IL-25), IL-33, and TSLP promote type 2 cyto-
kine-mediated immunity and inflammation by supporting den-
dritic cell, macrophage, mast cell, basophil, and innate lymphoid
cell (ILC) responses (Saenz et al., 2008; Siracusa et al., 2011;
Wills-Karp and Finkelman, 2011; Ziegler and Artis, 2010).
Further, we have previously demonstrated that IL-25 promotes
type 2 cytokine-mediated inflammation, in part by eliciting the
population expansion of progenitor cells termedmultipotent pro-
genitor type 2 (MPPtype2) cells in the periphery of mice (Saenz
et al., 2010, 2013). However, subsequent studies have reported
that human CD34+ progenitor-like cells show little responsive-
ness to IL-25 signaling (Allakhverdi and Delespesse, 2012), sug-
gesting that in some circumstances other pathways might
promote type 2 cytokine-associated EMH.
In this study, we demonstrate that TSLP promoted EMH,
which contributed to type 2 cytokine-associated inflammation.
Systemic TSLP expression resulted in increases in the frequency
and number of lineage negative (Lin) CD34+ c-Kit+ progenitor
cells in the spleen with a surface phenotype similar to that of
bone marrow (BM)-resident granulocyte-monocyte progenitor
(GMP) cells. In vitro and in vivo studies demonstrated that
TSLP-elicited progenitor cells exhibited multipotent potential
and developed into multiple myeloid effector cell populations.
Genome-wide transcriptional profiling of TSLP-elicited progeni-
tors revealed a distinct phenotype compared to BM-resident
GMPs, suggesting that TSLP-elicited progenitors were skewed
toward granulocyte development. In addition, TSLP-elicited pro-
genitors exhibited an increased capacity to develop into mast
cells and basophils and produced more IL-4 after differentiation
compared to BM-resident GMPs. Adoptive transfer of TSLP-eli-
cited progenitor cells promoted IL-4 production and protective
immunity to Trichuris muris. In addition, Lin CD34+ c-Kit+ cells
were identified in the spleen and blood of human donors and
were increased in the blood of allergic patients with a gain-of-
function polymorphism in TSLP that is associated with elevated
TSLP expression. Finally, a decrease in the percentage of pro-
genitor-like cells was associated with increases in mature gran-
ulocyte populations and allergic inflammation in the esophageal
biopsies of eosinophilic esophagitis (EoE) patients. These data
suggest that a portion of the granulocyte populations found in
the esophageal tissue in the context of active EoEmight develop
via EMH. Collectively, these studies identify a previously unrec-
ognized pathway of TSLP-dependent EMH that contributes to
Th2 cell-mediated inflammation and suggest that TSLP-elicited
EMH might be a therapeutic target in the treatment of allergic
inflammation in patients.
RESULTS
TSLP Elicits a Lin– CD34+ c-Kit+ Cell Population in the
Spleen
Recent studies demonstrated that PRR-expressing HSCs enter
the periphery, where they are capable of recognizing PAMPs
and undergoing EMH that contributes to antiviral and antibacte-Immrial immunity (Massberg et al., 2007; Nagai et al., 2006; Ratajczak
et al., 2010). However, whether EMH operates in a broader im-
mune context remains unknown. The epithelial cell-derived cyto-
kine TSLP has been shown to be critically important in promoting
type 2 cytokine-associated innate immune responses by influ-
encing terminally differentiated cells (Kim et al., 2013; Siracusa
et al., 2011; Ziegler and Artis, 2010). Further, we have previously
reported that TSLPR is expressed on BM-resident progenitor
cells and that TSLP can promote the development of basophils
from BM-resident progenitors (Siracusa et al., 2011), suggesting
that TSLP is capable of influencing central hematopoiesis in the
BM. In addition to progenitor cells in the BM, TSLPR is ex-
pressed on CD34+ progenitor cells in the periphery (Allakhverdi
et al., 2009; Osborn et al., 2004), although whether TSLP causes
CD34+ progenitor cells to undergo EMH is unknown. To directly
test whether TSLP can influence progenitor cell populations in
the periphery, we employed hydrodynamic tail-vein injections
of control cDNA (control-cDNA) or TSLP-encoding cDNA
(TSLP-cDNA) as a method of TSLP overexpression (Siracusa
et al., 2011) and examined CD34+ progenitor-like cell responses
in the spleen and blood. Following injection of TSLP-cDNA, sig-
nificant increases in the percentage and total number (Figures
1A–1C) of Lin CD34+ c-Kit+ cells, a phenotype consistent with
that of hematopoietic progenitors (Arinobu et al., 2005; Griseri
et al., 2012), were observed in the spleen, and increased cell
numbers were observed in the blood (see Figure S1A available
online) compared to control-cDNA-injected mice.
To determine whether a similar population expansion of Lin
CD34+ c-Kit+ progenitor-like cells in the periphery occurred in
thecontext of a natural stimulus associatedwith elevatedexpres-
sion of endogenous TSLP,we employed infectionwith Trichinella
spiralis, a helminth parasite in which optimal Th2 cell responses
are dependent on TSLP-TSLPR signaling (Giacomin et al.,
2012), and monitored progenitor-like cell responses in the
periphery. Critically, significant increases in the percentage and
total number (Figures 1D–1F) of Lin CD34+ c-Kit+ cells were
observed in the spleens of infectedmice compared to naive con-
trols. In addition to supporting the development of protective im-
munity to some helminth parasites, TSLP also promotes allergic
inflammation, including in the context of atopic dermatitis (AD)
(Kim et al., 2013; Ziegler and Artis, 2010). Therefore, WT mice
were treated topically with the vitamin D analog calcipotriol
(MC903), a protocol that induced TSLP-dependent AD-like
disease (Kim et al., 2013), and LinCD34+ c-Kit+ cells were eval-
uated. Topical treatment with MC903 resulted in a significant in-
crease in the percentage and total number of Lin CD34+ c-Kit+
cells in the spleen compared to ethanol (EtOH)-treated controls
(Figures S1B and S1C). Collectively, these data demonstrate
that TSLP production is associated with the population expan-
sion of Lin CD34+ c-Kit+ progenitor-like cells in the periphery
in the context of type 2 cytokine-associated inflammation.
To test whether increases in Lin CD34+ c-Kit+ cells in the
spleen were dependent on TSLP-TSLPR-signaling, we treated
Trichinella-infected mice with isotype control or an anti-TSLP
neutralizing antibody and examined progenitor-like cell re-
sponses. Compared to controls, anti-TSLP-treated mice failed
to demonstrate increases in the frequency or total number
(Figures S1D–S1F) of splenic Lin CD34+ c-Kit+ cells. Adminis-
tration of anti-TSLP neutralizing antibody also resulted inunity 39, 1158–1170, December 12, 2013 ª2013 Elsevier Inc. 1159
Figure 1. TSLP Promotes the Population Expan-
sion of Progenitor-like Cells
WT mice were injected with control plasmid (control-
cDNA) or TSLP-encoding cDNA plasmid (TSLP-cDNA),
and the percentage (A and B), and total number (C) of Lin
CD34+ c-Kit+ progenitor-like cells in the spleen were
quantified on day 5 after injection. WT mice were infected
with Trichinella spiralis, and the percentage (D and E), and
total number (F) of Lin CD34+ c-Kit+ progenitor-like cells
in the spleen were quantified on day 8 after injection. WT
mice were treated with ethanol (EtOH) or MC903 for
7 days. Groups of MC903-treated mice were treated with
isotype control or anti-TSLP neutralizing antibody, and
the percentage (G and H), and total number (I) of pro-
genitor-like cells in the spleen were quantified. Crlf2+/+
mice or Crlf2/ mice were treated with EtOH or MC903
for 7 days, and the percentage (J and K), and total number
(L) of progenitor-like cells in the spleen were quantified.
Results represent the mean ± SEM and numbers in the
plots indicate the percentage of cells. (B, C, E, F, K, and L)
Statistical analysis was performed with a Student’s t test.
(H and I) Statistical analysis was performed with a one-
way ANOVA and Tukey’s post hoc. (*p < 0.05), (**p < 0.01),
(***p < 0.001). All results are representative of at least
three separate experiments of at least three mice per
group per experiment. See also Figure S1.
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(Figures 1G–1I). Further, TSLPR-deficient (Crlf2/) mice failed
to exhibit MC903-induced increases in the percentage or total1160 Immunity 39, 1158–1170, December 12, 2013 ª2013 Elsevier Inc.number (Figures 1J–1L) of Lin CD34+ c-Kit+
cells compared to Crlf2+/+ controls. Collec-
tively, these gain- and loss-of-function studies
demonstrate that exogenous and endogenous
TSLP production is required for the population
expansion of progenitor-like cells in the spleen.
TSLP-Elicited Lin– CD34+ c-Kit+ Cells
Exhibit a GMP-like Phenotype
TSLP has been shown to regulate the popula-
tion expansion and activation of multiple innate
cell populations including ILCs (Kim et al., 2013;
Siracusa et al., 2011; Spits et al., 2013).
Although TSLP-elicited Lin CD34+ c-Kit+ cells
expressed CD127, ICOS, T1(ST2), and negative
to low amounts of Sca-1 compared to simulta-
neously run controls, they lacked high expres-
sion of the ILC-associated surface markers
CD90 and CD25 (Figure S2A) (Spits et al.,
2013). Further, principle component analysis
(PCA) of genome-wide transcriptional profiles
revealed that TSLP-elicited Lin CD34+ c-Kit+
cells were distinct from ILC populations (Fig-
ures S2B and S2C).
The surfacemarkers c-Kit andCD34 are high-
ly expressed on Lin BM-resident progenitor
cells, including GMPs (Arinobu et al., 2005; Gri-
seri et al., 2012). Therefore, to better charac-
terize the nature of TSLP-elicited Lin CD34+
c-Kit+ cells in the periphery, their expression ofsurface markers was examined and directly compared to that
of LinBM-resident GMPs that express CD34 and c-Kit (Arinobu
et al., 2005; Griseri et al., 2012). Consistent with published
Figure 2. TSLP-Elicited Progenitor Cells
Are GMP-like
BM-resident GMPs (A) were identified as Lin
CD34+ c-Kit+, and TSLP-elicited splenic progeni-
tor-like cells (C) were identified on day 5 after
TSLP-cDNA injection as Lin CD34+ c-Kit+.
Surface expression levels of Sca-1, CD16(32),
CD150, and TSLPR were determined (black line)
compared to fluorescence minus one (FMO) con-
trols (filled gray) on BM-resident GMPs (B) or
TSLP-elicited splenic progenitor cells (D). Results
are representative of at least three separate
experiments. See also Figure S2.
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nately Sca-1, CD16(32)hi, and CD150 and also expressed the
TSLPR (Figures 2A and 2B) (Arinobu et al., 2005; Griseri et al.,
2012). Similar toBM-residentGMPs, LinCD34+ c-Kit+ TSLP-eli-
cited progenitor-like cells were Sca-1lo, CD16(32)+, CD150int,
and TSLPR+ (Figure 2C and 2D). These data demonstrate that
TSLP-elicited progenitor cells in the spleen resemble BM-resi-
dent GMPs and are GMP-like.
TSLP-Elicited GMP-like Cells Exhibit Multipotent
Potential In Vitro
To directly test whether TSLP-elicited Lin CD34+, c-Kit+ GMP-
like cells exhibit multipotent potential, they were sort purified
(Figures 3A and 3B) on day 5 after TSLP-cDNA injection and
cultured in the presence of the hematopoietic cytokine IL-3.
On day 5 after culture, CD11b+ and CD11b cell fractions
were readily identified (Figure 3C). Among the CD11b+ fraction
of cells, CD115+ macrophages (Figure 3D) and Ly6G+ neutro-
phils (Figure 3E) were identified, whereas within the CD11b
fraction, FcεRI+ CD49b+ basophils (Figure 3F) and FcεRI+
c-Kit+ mast cells (Figure 3G) were identified. Cytologic analysis
of progeny at day 5 after culture also revealed cell morphologies
consistent with those of mature macrophages, neutrophils,
basophils, and mast cells (Figure 3H). Consistent with the pres-
ence of mature granulocyte populations, robust levels of IL-4
were detected in IL-3-treated cultures (Figure 3I). In addition,
an average of approximately 1 3 105 live cells were recovered
from 1 3 104 input cells from IL-3-treated cultures (Figure 3J).
Similar results were observed from cultures treated with stem
cell factor (SCF) and IL-3 together (data not shown). Critically,
TSLP-elicited GMP-like cells did not exhibit the ability to
develop into lymphoid cells when cultured on Delta ligand-
expressing OP9 cells in the presence of Flt3 ligand and IL-7
(data not shown) (Holmes and Zuniga-Pflucker, 2009). Collec-
tively, these data indicate that TSLP-elicited progenitors prolif-
erate and possess the potential to develop into cells of the
myeloid lineage.
To further evaluate the developmental potential of TSLP-eli-
cited GMP-like cells, we sort-purified and dispersed them in a
methocult matrix. TSLP-elicited GMP-like cells were capable
of developing into colony-forming unit granulocyte macrophage
(CFU-GM), CFU-G, and CFU-M colonies, suggesting that theyImmpossess similar developmental potential as BM-GMPs (Fig-
ure 3K) (Ito et al., 2003). Further, macrophages, mast cells, and
basophils were identified by flow cytometric analysis in isolated
single colonies (Figure 3L). Collectively, these data demonstrate
that TSLP-elicited GMP-like cells possess multipotent potential
in vitro.
TSLP-Elicited GMP-like Cells Exhibit Multipotent
Potential In Vivo
To directly test the in vivo multipotent potential of TSLP-elicited
GMP-like cells, we injected CD45.1+ mice with TSLP-cDNA, and
GMP-like cells were sort purified on day 5 after injection. Isolated
TSLP-elicited progenitors were adoptively transferred into con-
genic mice that received a TSLP-cDNA injection 1 day prior to
the cell transfer (Figure S3A). On day 5 after transfer, CD11b+
and CD11b donor cells were identified (Figures S3B and
S3C). Among the CD11b+ fraction of cells, CD115+ macrophage
populations were identified (Figure S3D), whereas among the
CD11b fraction, FcεRI+ CD49b+ basophils and FcεRI+ c-Kit+
mast cells (Figures S3E and S3F) were identified. In addition,
in vivo transfers revealed that TSLP-elicited GMP-like cells
also differentiated into small but detectable populations of
CD11c+ dendritic cells, CD11b+ Ly6G+ neutrophils and
CD11b+ Siglec-F+ eosinophils (Figure S3G). Collectively, these
studies demonstrated the multipotent potential of TSLP-elicited
GMP-like cells to develop into multiple effector cell populations
in vivo.
TSLP-Elicited GMP-like Cells Are IL-25-Independent
and Distinct from MPPtype2 Cells
Previous studies demonstrated that IL-25 promotes a Lin Sca-
1+ c-Kit+ progenitor cell population termed MPPtype2 cells in the
gut associated lymphoid tissues (GALT) that express low levels
of CD34 (Saenz et al., 2010). Therefore, to determine whether
TSLP-elicited GMP-like cells were dependent on IL-25-IL-25R
signaling, WT or IL-25R-deficient mice (Il17rb/) were treated
with ethanol or MC903, and TSLP-elicited GMP-like cells were
evaluated. Similar to WT mice (Figures S4A–S4C), IL-25R-defi-
cient mice treated with MC903 exhibited a significant population
expansion of TSLP-elicited GMP-like cells (Figures S4A–S4C).
Next, we directly compared the genome-wide transcriptional
profiles of TSLP-elicited GMP-like cells versus MPPtype2 cells.unity 39, 1158–1170, December 12, 2013 ª2013 Elsevier Inc. 1161
Figure 3. TSLP-Elicited GMP-like Cells
Possess Multipotent Potential
Lin CD34+ c-Kit+ TSLP-elicited progenitor-like
cells (A) in the spleen were sort purified on day 5
after TSLP-cDNA injection and cultured in media
alone or 10 ng/mL of IL-3. On day 5 after culture,
CD11b+ and CD11b cell fractions (C), CD11b+
CD115+ macrophages (D), CD11b+ Ly6G+ neu-
trophils (E), CD11b FcεRI+ CD49b+ basophils (F),
and CD11b FcεRI+ c-Kit+ mast cells (G) were
identified by flow cytometry. Cytology of sort pu-
rified TSLP-elicited progenitor cells (B) and post-
culture progeny were performed (H). IL-4 levels (I)
were determined by ELISA, and the number of live
cells (J) were evaluated. Representative CFU-GM,
CFU-G, and CFU-M colonies (K) identified post-
methocult assay. Results represent the mean ±
SEM and numbers in the plots indicate the per-
centage of cells. Representative flow cytometric
analysis of a CFU-GM colony (L). All results are
representative of at least three separate experi-
ments. See also Figure S3.
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elicited GMP-like cells exhibited substantially different
genome-wide transcriptional profiles compared to IL-25-elicited
MPPtype2 cells (Figure S4D). Collectively, these data suggested
that TSLP-elicited GMP-like cells represented a distinct cell pop-
ulation from MPPtype2 cells.1162 Immunity 39, 1158–1170, December 12, 2013 ª2013 Elsevier Inc.TSLP-Elicited GMP-like Cells Are a
Distinct Progenitor Cell Population
Recent studies have shown that progeni-
tor cell populations accumulate in the peri-
phery, undergoEMH,andcontribute to the
developmentof inflammation (Griseri etal.,
2012; Saenz et al., 2010). However, the
functional potential of peripheral progeni-
tor cell populations and how they differ
from BM-resident progenitor cells remain
to be fully defined. To further explore the
differences between TSLP-elicited GMP-
like cells and BM-resident GMPs, we
compared the genome-wide transcrip-
tional profiles of these distinct cell popula-
tions. Critically, TSLP-elicited GMP-like
cells and BM-resident GMPs differentially
expressed 575 genes at a 2-fold or
greater level (Figure 4A). These data sug-
gest that TSLP-elicited GMP-like cells
might possess unique functional potential.
To further compare TSLP-elicited
GMP-like cells and BM-resident GMPs,
we performed analysis of the 200 most
differentially expressed genes (Figure 4B)
by using the Database for Annotation,
Visualization and Integrated Discovery
(DAVID) (Dennis et al., 2003). DAVID anal-
ysis revealed a transcriptional signature of
BM-resident GMPs that was enriched for
pathways associated with host defenseagainst bacteria (Figure 4C; Figure S4E). In contrast, TSLP-
elicited GMP-like cells were enriched for pathways consistent
with biological adhesion, cell activation, growth factor binding,
and cytokine binding (Figure 4C; Figure 4E).
To further compare the profiles of these two cell populations,
we performed gene-set enrichment analysis (GSEA) (Siracusa
Figure 4. TSLP-Elicited GMP-like Cells Exhibit
Distinct Transcriptional Profiles
BM-resident GMPs (BM GMP) or TSLP-elicited GMP-
like cells (TSLP GMP-like) were sort purified on day 5
after TSLP-cDNA injection, and genome-wide tran-
scriptional analysis was undertaken. Venn diagram
illustrating shared and uniquely expressed genes at
levels 2-fold or greater between BM-resident GMPs or
TSLP-elicited GMP-like cells (A). Heatmap presenta-
tion of gene-expression profiles illustrating 100 of the
top 200 genes with the greatest differences in
expression (red, high; blue, low) in BM-resident GMPs
versus TSLP-elicited progenitor-like cells (B). The top
200 differentially expressed genes were run through
DAVID, and significantly enriched transcriptional
pathways were identified (GO term) (C). GSEA analysis
illustrating enrichment of coordinated gene sets. Gene
sets enriched toward BM GMPs (blue gradient) and
gene sets enriched in TSLP GMP-like cell gene sig-
natures (red gradient) are indicated by enrichment
scores (D). Data are representative of one experiment
with three biological replicates per cell type. See also
Figure S5.
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genitor cells were enriched for gene signatures consistent
with hematopoietic stem cells and hematopoietic progenitorImmunity 39, 1158–1170,cells, respectively (Figure 4D; Figure 4F).
Consistent with published reports, GSEA
of BM-resident GMP profiles identified
expression patterns enriched for Toll-like re-
ceptor (TLR) pathway signaling and innate
immune surveillance (Figure 4D; Figure 4F)
(Massberg et al., 2007; Nagai et al., 2006).
In contrast, GSEA of TSLP-elicited GMP-
like cells revealed gene-expression profiles
enriched for genes associated with breast
cancer tumors, hematopoietic stem cell
mobilization, Runx1 expression, Runx1
expression associated with granulocyte
development, and CEBPa expression (Fig-
ure 4D; Figure 4F). Critically, EMH and
TSLP expression have been linked to the
progression of breast cancer, and both
Runx1 expression and CEBPa expression
are associated with the commitment and
differentiation of progenitor cell populations
into granulocyte cell lineages (Arinobu et al.,
2005; Millar et al., 2009; Mukai et al., 2012;
Pedroza-Gonzalez et al., 2011; Wang and
Darvishian, 2006). These data suggest that
TSLP-elicited GMP-like cells might have
a heightened capacity to develop into
granulocytes.
TSLP-Elicited GMP-like Cells Exhibit
Enhanced Capacity to Promote Type 2
Cytokine Responses
The data presented above suggest that
TSLP-elicited GMP-like cells might beskewed toward differentiating into granulocyte populations
compared to BM-resident GMP populations. To directly test
this, we directly compared the multipotent potential of theseDecember 12, 2013 ª2013 Elsevier Inc. 1163
Figure 5. TSLP-Elicited GMP-like Cells
Preferentially Differentiate into IL-4-Pro-
ducing Granulocytes
BM-resident GMPs (A) or TSLP-elicited GMP-like
cells (C) were sort-purified and cultured with
10 ng/mL of IL-3. CD11b+ and CD11b cell frac-
tions were quantified in BM-resident GMP cultures
(BM-GMP) (B) or TSLP-elicited GMP-like cell
cultures (TSLP-GMP) (D). The total number of
CD11b+ cells, CD11b cells, macrophages, neu-
trophils, basophils, or mast cells was identified
in BM-GMP cultures or TSLP-GMP cultures (E
and F). IL-4 was measured in after culture super-
natants by ELISA (G). GM-CSF + LPS initiated
GMP-like cells or TSLP-elicited GMP-like cells
were sort purified from the spleens of mice and
transferred in the skin of naive mice. Pathology (H)
and spontaneous IL-4 production in the draining
LN (I) were compared to PBS injected controls.
(A–D) Representative flow cytometric plots. (E–G)
Results represent the mean ± SEM and are
compiled from three separate experiments.
Numbers in the gates indicate the percentage of
cells. (H and I) Results are representative of three
separate experiments. Statistical analysis was
performed with a two-way ANOVA. (**p < 0.01),
(***p < 0.001). Scale bars represent 100 mm.
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and TSLP-elicited GMP-like cells (Figure 5C) were sort-purified
and cultured with the hematopoietic cytokine IL-3. On day 5 after
culture, CD11b+ and CD11b cell fractions were readily identi-
fied in cultures seeded with BM-resident GMPs (Figure 5B) or
TSLP-elicited GMP-like cells (Figure 5D). Although there was
no difference in the number of live cells recovered from either
set of cultures (data not shown), BM-resident GMPs developed
into more CD11b+ macrophages and neutrophils than did
TSLP-elicited GMP-like cells (Figure 5E). Conversely, TSLP-
elicited GMPs developed into more CD11b basophils and
mast cells (Figure 5F). Further, increases in the number of baso-
phils andmast cells also correlated with increases in the levels of
IL-4 in the supernatants of TSLP-elicited GMP-like cell cultures
(Figures 5F and 5G). Collectively, these data indicated that
TSLP-elicited progenitor cells possessed an enhanced capacity
to differentiate into mast cell and basophil populations
compared to BM-resident progenitors and thus might be more
potent at promoting type 2 cytokine responses than other pro-
genitor cell populations.
Previous studies have demonstrated that multiple cytokines
and growth factors promote the accumulation of peripheral pro-
genitor cells in the context of Th1 and Th17 cell-associated
inflammation (Griseri et al., 2012; Papayannopoulou, 1999;1164 Immunity 39, 1158–1170, December 12, 2013 ª2013 Elsevier Inc.Schuettpelz and Link, 2013). Our findings
demonstrate that TSLP elicits a distinct
GMP-like cell population in the context
of type 2 cytokine responses (Figure 1),
suggesting that TSLP-elicited GMP-like
cells might be specialized to promote
Th2 cell responses. To directly test this,
we sort purified splenic TSLP-elicitedGMP-like or GM-CSF + LPS-elicited GMP-like cells, injected
them into the skin of naive mice, and monitored their ability to
promote pathology and type 2 cytokine production (Saenz
et al., 2013). Consistent with an ability to promote type 2 cytokine
responses, TSLP-elicited GMP-like cells were more potent in-
ducers of skin inflammation characterized by a mixed dermal in-
flammatory infiltrate and edema (Figure 5H) and IL-4 production
in the LN (Figure 5I). These data suggested that TSLP-elicited
GMPs were primed to promote type 2 cytokine responses.
To further evaluate the ability of TSLP-elicited GMP-like cells
to contribute to the development of type 2 cytokine responses
in vivo, TSLP-elicited GMP-like cells were transferred into
Trichuris muris-infected TSLPR-deficient mice (Crlf2/).
Consistent with previous reports (Taylor et al., 2009),
Trichuris-infected Crlf2/ mice exhibited decreased produc-
tion of type 2 cytokines (IL-4, IL-5, and IL-13), decreased serum
immunoglobulin E (IgE) titers, a loss of goblet cell hyperplasia,
and increased worm burdens (Figures 6A–6D) compared to
Crlf2+/+ mice. Critically, adoptive transfer of TSLP-elicited
GMP-like cells into infected Crlf2/ mice (Crlf2/ + GMP-
like) was sufficient to partially restore type 2 cytokine produc-
tion (Figure 6A), serum IgE levels (Figure 6B), and goblet cell
hyperplasia (Figure 6C) and significantly reduce worm burdens
(Figure 6D). Together, these data suggest that TSLP-elicited
Figure 6. TSLP-Elicited GMP-like Cells
Contribute to Type 2 Cytokine Responses
In Vivo
Crlf2+/+orCrlf2/micewere infectedwithTrichuris
muris, and on days 10–15 after infection, one group
of Crlf2/ mice received TSLP-elicited GMP-like
cells (Crlf2/+GMP-like).Onday21postinfection,
mesenteric lymphnode (mLN)cellswere stimulated
with Trichuris antigen, and IL-4, IL-5, and IL-13
production (A) and serum IgE titers (B) were deter-
mined. Intestinal mucin production by PAS/alcian
blue stainingwas examined (C), andwormburdens
were determined (D). Results represent themean ±
SEM. Results are representative of two separate
experiments (Crlf2+/+; n = 8) (Crlf2/; n = 8)
(Crlf2/ +GMP-like; n = 6). Statistical analysis was
performed with a two-tailed Mann-Whitney t test.
(*p < 0.05). Scale bars represent 100 mm.
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responses in vivo.
Human GMP-like Cell Responses Are Associated with a
Gain-of-Function Polymorphism in TSLP and Allergic
Inflammation
To determine whether a similar population of Lin CD34+ c-Kit+
progenitor-like cells could be identified in the spleens of humans,
we collected splenic tissue from ten human organ donors and
examined it for the presence of progenitor-like cells. Critically,
Lin CD34+ c-Kit+ cells were found in all ten human samples
examined (Figure 7A). Further, Lin CD34+ c-Kit+ GMP-like cells
were also identified in the peripheral blood of human subjects
(Figure 7B). To determine whether human GMP-like cells
possess multipotent potential, we sort purified Lin CD34+
c-Kit+ cells from the blood of patients and performed methocult
assays. Consistent with murine GMP-like cells, human progeni-
tor-like cells readily produced CFU-GM, indicating they were
GMP-like (Gribaldo et al., 1999) (Figure 7C).
Next, we examined the frequencies of Lin CD34+ c-Kit+
cells in the peripheral blood (Figure 7B) of allergic patients
suffering from EoE. EoE is an allergic inflammatory disease
that causes symptoms such as dysphagia and food impaction
(Noti et al., 2013). Although the causes of EoE remain un-
known, a subset of EoE patients possess a gain-of-function
single-nucleotide polymorphism (SNP) rs3806932 in TSLP
that is associated with elevated TSLP expression and elevated
granulocyte responses in the periphery (Noti et al., 2013; Roth-
enberg et al., 2010; Sherrill et al., 2010). Critically, allergic
patients with the SNP rs3806932 (SNP+) presented with
increased frequencies of Lin CD34+ c-Kit+ cells in their pe-
ripheral blood compared to patients lacking a gain-of-function
polymorphism (control) (Figure 7D). These data indicate that
the TSLP-EMH pathway is conserved and active in mice andImmunity 39, 1158–1170, Dehumans and might contribute to the
development of allergic inflammation.
The symptoms of EoE are thought to
result from chronic esophageal inflam-
mation and pathophysiological changes
in esophageal tissues associated withthe accumulation of granulocytes such as basophils and eosin-
ophils (Noti et al., 2013). However, whether mature granulocytes
are recruited to the esophageal tissue or whether these cells
develop in the tissue via EMH remains unknown. Therefore, we
evaluated the relationship between progenitor-like cells and
granulocytes in esophageal biopsies from control patients, pat-
ents with active EoE, and patients with inactive EoE. Critically,
patients with active EoE had significantly decreased frequencies
of progenitor-like cells in their biopsies compared to healthy con-
trols. Further, frequencies of progenitor-like cells were restored
back to control levels in patients with inactive EoE, demon-
strating that progenitor cells were negatively associated with
active disease (Figure 7E). Additionally, reductions in progeni-
tor-like cells were associated with a significant increase in
frequencies of FcεRI+ granulocytes in esophageal biopsies (Fig-
ure 7F). Collectively, these data suggest that progenitor-like cells
in esophageal tissues of patients with active EoE might differen-
tiate via EMH into mature granulocytes and contribute to the
development of allergic inflammation associated with EoE.
DISCUSSION
In this study, we demonstrated a previously unrecognized role
for TSLP-elicited EMH in contributing to the development of
type 2 cytokine-dependent immunity and inflammation. Exoge-
nous and endogenous TSLP induced the population expansion
of murine Lin CD34+ c-Kit+ progenitor cells in the context
of type 2 cytokine-associated infection or inflammation, and
disruption of the TSLP-TSLPR signaling pathway prevented
the accumulation of progenitor cells in the periphery. TSLP-
elicited Lin CD34+ c-Kit+ cells were found to phenotypically
resemble BM-resident GMPs, indicating that they possess
GMP-like qualities. However, genome-wide transcriptional
profiling and functional assays demonstrated that TSLP-elicitedcember 12, 2013 ª2013 Elsevier Inc. 1165
Figure 7. Progenitor Cell Responses Are
Associated with a Gain-of-Function Poly-
morphism in TSLP and Allergic Inflam-
mation
Lin (CD3, TCRab, CD11c, CD19, CD56,
FcεRI) CD34+ c-Kit+ cells were identified in the
spleens of 10 human organ donors (A). Lin FcεRI
CD34+ c-Kit+ progenitor-like cells were identified
(percentage of parent gate is displayed) (B) and
sort purified from the blood of healthy patients,
and CFU-GM colonies were identified after me-
thocult assay (C). Lin CD34+ c-Kit+ progenitor-
like cells were quantified in the peripheral blood of
allergic patients with no copies (control, n = 7), or
at least one copy of SNP rs3806932 (SNP+, n = 37)
(D). Esophageal biopsies were taken from healthy
control patients (n = 19), patients with active EoE
(n = 16), or patients with inactive EoE (n = 15), and
the percentage of Lin FcεRI CD34+ c-Kitvariable
progenitor-like cells (E) and Lin FcεRI+ gran-
ulocytes (F) were determined by flow cytometric
analysis. Results represent the mean ± SEM, and
numbers in the plots indicate the percentage of
cells. Statistical analysis was performed with a
two-tailed Mann-Whitney t test. (*p < 0.05), (**p <
0.01), (***p < 0.001). (C) Results are representative
of two blood donors and eight technical replicates.
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sors and producedmore IL-4 than BM-resident GMPs. Critically,
adoptive transfer of TSLP-elicited GMP-like cells preferentially
promoted type 2 cytokine production compared to GM-CSF +
LPS-elicited GMP-like cells and was sufficient to partially restore
Th2 cell responses and protective immunity to Trichuris in
normally susceptible mice. These data demonstrated that in
contrast to other peripheral progenitor cell populations, TSLP-
elicited GMP-like cells appear to preferentially promote type 2
cytokine responses.
Employing translational approaches, we also demonstrated
that EoE patients with a gain-of-function polymorphism associ-1166 Immunity 39, 1158–1170, December 12, 2013 ª2013 Elsevier Inc.ated with elevated expression of TSLP
have significantly increased progenitor
cell populations in their peripheral blood.
Further, we showed that reduced progen-
itor-like cell populations were associated
with increased granulocyte populations in
the context of EoE. These data suggest
that granulocyte populations found in
the esophageal tissue in the context of
active EoE might be derived, at least
in part, from local progenitor cells
that undergo EMH. These translational
studies suggest a link between elevated
TSLP expression, an increased potential
for EMH, and increased granulocyte re-
sponses in human patients suffering
from allergic inflammation.
TSLP was originally isolated from a
mouse thymic stromal cell line and was
first defined as a lymphocyte growthfactor (Ziegler and Artis, 2010). It is now appreciated that
TSLP can promote type 2 cytokine-mediated inflammation by
regulating multiple terminally differentiated cell types (Al-Shami
et al., 2004; Allakhverdi et al., 2007; Ito et al., 2005; Kim et al.,
2013; Lu et al., 2009; Reche et al., 2001; Siracusa et al., 2011;
Ziegler and Artis, 2010). The data presented in this manuscript
identify a previously unrecognized role for TSLP as a critical
regulator of EMH and suggest that in addition to activating
terminally differentiated cells and promoting the central hema-
topoiesis of basophils, TSLP regulates EMH and influences the
development of multiple myeloid effector cells in peripheral
tissues.
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cytokines critically support type 2 cytokine-associated innate
immune responses (Ho et al., 2007; Noti et al., 2013; Saenz
et al., 2010; Saenz et al., 2008; Siracusa et al., 2011; Wills-
Karp and Finkelman, 2011; Ziegler and Artis, 2010). For example,
IL-25, IL-33, and TSLP promote the accumulation of ILCs that
contribute to the development of type 2 cytokine-mediated
inflammation (Spits and Cupedo, 2012; Walker et al., 2013). In
addition to promoting ILC responses, our new findings demon-
strated for the first time that TSLP supports the development
of multiple myeloid effector cells and elicits type 2 cytokine
responses by directly regulating the presence of progenitor cells
in the periphery and by promoting EMH.
TSLP is strongly associated with multiple human disease
states and the development of type 2 cytokine-mediated inflam-
mation in the skin, lung, and digestive tract. For example, genetic
analyses of patient populations have demonstrated that gain-of-
function mutations in the genes encoding TSLP or its receptor
are associated with the development of asthma, allergic rhinitis,
and EoE (Bunyavanich et al., 2011; Harada et al., 2010; Hunning-
hake et al., 2010; Sherrill et al., 2010). Further, exaggerated TSLP
production has been observed in patients suffering from AD,
asthma, and EoE (Sherrill et al., 2010; Soumelis et al., 2002;
Ying et al., 2005). Critically, our findings demonstrated that
patients with a gain-of-function polymorphism in TSLP and
suffering from EoE presented with exaggerated frequencies
of Lin CD34+ c-Kit+ cells in their peripheral blood. Further, we
demonstrated that reduced progenitor cell populations were
associated with increased mature granulocyte responses and
allergic inflammation in the esophagus, suggesting that TSLP-
elicited EMH might contribute to EoE-associated inflammation
in humans. These data provide a link between elevated TSLP
expression and progenitor cell responses in the periphery of hu-
man patients suffering from type 2 cytokine-associated disease.
However, more extensive genetics-based studies are necessary
to evaluate the relationships between a gain-of-function poly-
morphism in TSLP, EMH, and EoE.
TLR-expressing HSCs are known to exit the BM and are
thought to patrol the periphery in a manner that allows them
to provide an immediate source of myeloid cells that can
contribute to host microbial defense (Massberg et al., 2007;
Nagai et al., 2006). Further, peripheral tissue compartments
such as the spleen and blood are thought to provide a reservoir
of undifferentiated myeloid cells that are primed for rapid
deployment and function as critical regulators of inflammation
(Swirski et al., 2009). More recently, it has been shown that
GMPs accumulate in the spleen and colon following the induc-
tion of chronic intestinal inflammation and contribute to proin-
flammatory responses in the gut (Griseri et al., 2012). However,
the role of EMH in promoting the induction of type 2 cytokine-
mediated inflammation has remained less well defined. The
data presented here demonstrate that TSLP-elicited EMH
directly contributes to Th2 cell responses and suggest that
EMH is capable of influencing multiple modules of the innate
and adaptive immune system.
In conclusion, data presented here demonstrating that
TSLP-elicited EMH promotes type 2 cytokine-mediated inflam-
mation—coupled with previous reports demonstrating the con-
tributions of EMH in other settings (Griseri et al., 2012; MassbergImmet al., 2007; Nagai et al., 2006; Swirski et al., 2009)—indicate that
EMHmight be a conserved aspect of innate immunity in multiple
infectious and inflammatory contexts. The alteration of stem cell
populations by modifying transcription factors or epigenetic
events is recognized for its therapeutic potential to replace
damaged cells or to regenerate damaged tissues (Robinton
and Daley, 2012; Sharkis et al., 2012). Our present study sug-
gests that in addition to the therapeutic potential of targeting
stem cells in regenerative medicine, altering the migration and
differentiation potential of pluripotent HSCs might represent a
therapeutic approach to regulate type 2 inflammation in the
context of helminth infections, asthma, allergies, and cancer.
EXPERIMENTAL PROCEDURES
Mice
C57BL(6) wild-type (WT) mice were purchased from Charles River Laboratory.
Crlf2/ mice and Il17rb/ were provided by Amgen via Charles River Labo-
ratory. Congenic mice were purchased from NCI. Mice were maintained in
specific pathogen-free facilities at the University of Pennsylvania. All protocols
were approved by the University of Pennsylvania Institutional Animal Care and
Use Committee (IACUC).
Flow Cytometry
Cells were stained with monoclonal anti-mouse fluorescently conjugated an-
tibodies: Sca-1 (D7), c-Kit (2B8), CD4 (GK1.5), CD8 (SK1), CD5 (53–73), NK1.1
(PK136), CD11b (MI/70), CD11c (N418), CD45.1 (A20), CD45.2 (104),
CD16(32) (93), CD127 (A7R34), ICOS (7E.17G9), CD90 (53-2.1), and CD25
(PC61.5) from eBioscience; CD34 (RAM34) from BD PharMingen; and
T1(ST2) biotinylated mAb from MD Biosciences; or monoclonal anti-human
fluorescently conjugated antibodies: CD19 (HIB19), FcεRI (AER-37), CD34
(4H11), and c-Kit (61D3) from eBioscience; TCRab (ID26) and CD56 (B159)
from BD PharMingen; and CD11c (551077) from Miltenyi Biotech. Anti-mouse
TSLPR antibody was provided by Amgen. Samples were acquired on a BD
LSRII flow cytometer (BD Biosciences) and analyzed with FlowJo software
(v9.2, Tree Star). Cell sorting was performed with a FACSAriaII (BD
Bioscience).
Microarray Gene-Expression Profiling
TSLP-elicited GMP-like cells (Lin CD34+ c-kit+) were sort-purified from the
spleen of C57BL(6) mice on day 5 after TSLP-cDNA treatment. BM-resident
GMPs (Lin Sca1 c-kit+ CD34+ CD16[32]+) were sort-purified from mice
that received a control-cDNA injection. IL-25-elicited MPPtype2 cells (Lin
T1[ST2] IL-7Ra CD90 CD25 c-kit+) were sort purified from the MLN
and PECs of C57BL(6) mice on day 7 after IL-25 treatment (Saenz et al.,
2013). Lineage markers included CD3ε, CD4, CD8a, CD19, CD11b, CD11c,
and NK1.1. Three biological replicates were collected, each consisting of
50,000 cells. mRNA was isolated, amplified, and hybridized to the Mouse
Gene 1.0ST genechip (Affymetrix). The GEO accession number for the
transcriptional profiles reported in this paper is GSE52485. With the
ClassNeighbors function in GenePattern, differentially expressed genes
(fold-change > 2, p < 0.05) were identified. Gene pathways were analyzed
with DAVID. GSEA of the top 100 differentially expressed genes from each
biological group was performed. PCA (Saenz et al., 2013) and Euclidean dis-
tance measurements were performed with R (R Core Team), and hierarchical
clustering analysis was performed with Unweighted Pair Group Method with
Arithmetic Mean (UPGMA) algorithm. Analysis plot compares transcriptional
profiles for TSLP-elicited GMP-like cells (TSLP-GMP), natural helper cells
(NHC) (GSE18752), lung-resident ILCs (lung ILC) (GSE46468), splenic
lymphoid tissue-inducer cells (LTi) (GSE46468), and fetal lymphoid tissue-
inducer cells (fLTi) (GSE18752).
In Vitro Differentiation Assay
Spleens of TSLP-cDNA-treated mice were isolated on day 5 after injection,
and single-cell suspensions were made. GMP-like cells were identified as
Lin (CD3, CD4, CD5, CD8, CD19, CD11b, CD11c, NK1.1, and FcεRI), andunity 39, 1158–1170, December 12, 2013 ª2013 Elsevier Inc. 1167
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200 ml of complete RPMI in the presence or absence of 10 ng/mL of rIL-3
(R&D Systems). Fresh rIL-3 was added on day 3 after transfer. On day 5, cell
populations were evaluated, and cytokine was measured by standard ELISA
(Saenz et al., 2010).
Methocult Assays
TSLP-elicited GMP-like cells were sort-purified and processed according to
themanufacturer’s protocol (Methocult GFM3434, STEMCELL Technologies).
GMP-like cells were sort-purified from the blood of healthy human donors
and processed according to the manufacturer’s protocol (Methocult H4035
Optimum, STEMCELL Technologies).
In Vivo Differentiation Assay
We sort purified 3 3 104 TSLP-elicited GMP-like cells from the spleen of
CD45.1+ mice and adoptively transferred intraperitoneally (i.p.) into CD45.2+
congenic mice that received a TSLP-cDNA injection 1 day prior to the cell
transfer. On day 5 after transfer, peritoneal cells were collected and flow cyto-
metric analysis was performed.
MC903, Antibody Treatments, Hydrodynamic Tail-Vein Injections,
and Trichinella spiralis Infections
C57BL(6), Crlf2/, or Il17rb/ mice were treated as previously described
(Kim et al., 2013). C57BL(6) mice were administered Rat IgG isotype or
anti-TSLP neutralizing antibody (i.p.) as previously described (Kim et al.,
2013). C57BL(6) administered cDNA plasmids as previously described
(Siracusa et al., 2011). Mice were infected with 300 Trichinella muscle
larvae by oral gavage and sacrificed on day 8 after infection (Giacomin
et al., 2012).
Intradermal Injections
We suspended 2 3 104 sort purified BM-resident GMPs or TSLP-elicited
GMP-like cells in 50 ml of PBS and injected them intradermally into C57BL(6)
mice. Controls were PBS injected. At day 5 after infection, draining LNs
were collected and spontaneous cytokine production was evaluated after
48 hr by ELISA (eBioscience).
Trichuris muris Infection
WT and Crlf2/ mice were infected with Trichuris muris as previously
described (Taylor et al., 2009), and on days 5–10 after infection, one group
of Crlf2/ mice received 3 3 104 – 2 3 105 sort purified TSLP-cDNA-elicited
GMP-like cells from WT mice. On day 21 postinfection, T. muris antigen-spe-
cific type 2 cytokine responses, serum IgE, pathology, and worm burdens
were evaluated.
Human Patients and Sample Preparation
Pediatric patients at the University of Pennsylvania Penn-CHOP Joint Center
for Digestive, Liver and Pancreatic Medicine or the Center for Pediatric Eosin-
ophilic Disorders at CHOP were analyzed and were provided to M.-L.W. and
A.J.B under protocols approved by the CHOP IRB. EoE patients were defined
as previously described (Noti et al., 2013). Patients with inactive EoE were
defined as previously described (Noti et al., 2013). Peripheral blood from
genotyped pediatric patients was collected and processed as previously
described (Noti et al., 2013).
Written consent was obtained from all participants or their parents or
legal guardians, and for pediatric participants, verbal assent from the child
was additionally obtained as described in IRB approved protocols.
Statistical Analysis
Results represent the mean ± SEM unless indicated otherwise. For murine
studies, statistical significance was determined by unpaired Student’s t test,
one-way ANOVA, or two-way ANOVA as indicated. For patient studies, a
nonparametric, two-tailed Mann-Whitney t test was used to compare means.
Statistical analyses were performed with Prism GraphPad software v5.0
(*p < 0.05), (**p < 0.01), (***p < 0.001).1168 Immunity 39, 1158–1170, December 12, 2013 ª2013 Elsevier InACCESSION NUMBERS
The GEO accession number for the transcriptional profiles reported in this
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